Groundbreaking science attracts partners and investors
BioArctic’s work is based on groundbreaking scientific discoveries, and our researchers collaborate with strategic partners such as researchers at universities and big pharma companies. We have vast scientific competence and years of experience in developing drugs from idea to market.
BioArctic’s business model involves the company initially pursuing project development in-house and, once the project has reached a phase of development requiring more resources or competence, signing collaboration agreements and partnership agreements or licensing certain commercial rights to global pharma companies.
Based on our cutting-edge expertise in neurodegenerative disorders, we have built a broad and well-diversified project portfolio with the potential to improve the health of patients. The diversity of projects in various phases of development provides a solid basis for creating value for patients, their families, and society as a whole. This makes us an attractive company to both partners and investors.